Share this Page:
Research published by the Mayo Clinic in America has shown that surgery could more than double life expectancy for many patients with late-stage kidney cancer, giving them up to 10 years more than they would have had without the surgery. The study was published recently in The Journal of Urology, and reported a “clinically meaningful difference in survival” between people with renal cell carcinoma (RCC) who had had surgery to completely remove secondary tumour growths, called metastases, compared to those who didn’t. Patient who had surgery to remove metastases were about half as likely to have died from metastatic RCC at every time point in the study.
